Paydirt

AL

Insider

ADAR1 Capital Management, LLC

10% owner

ADAR1 Capital Management, LLC (10% owner) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 6 priced purchase filings, the average 21-session return was +9.6% from execution and +15.9% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+9.6%

avg across 6 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+15.9%

same 6 filings, from disclosure

Filings, ttm

9

9 buys · 0 sells

Median delay

2d

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$11.0M

shares × price, as filed

Last traded

Sep 3

Filed Sep 8

Median ADV $8.3M across their filed names

33% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Impact on $10,000 · 12M

$16,165 (+61.7%)

S&P 500 $11,725 (+17.2%) · 44.4 pts ahead

ADAR1 Capital Management, LLC S&P 500

Compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $11.0M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

Rallybio Corporation RLYB · 4 buys · 0 sells 4 filings TENX

Tenax Therapeutics, Inc. TENX · 3 buys · 0 sells 3 filings INM

InMed Pharmaceuticals Inc. INM · 1 buy · 0 sells 1 filing NXTC NextCure, Inc. NXTC · 1 buy · 0 sells 1 filing

Recent filings

RLYBPURCHASE Rallybio Corporation View filing → $2.1M
152,005 sh across 2 lots
Exec May 4
Filed May 6 · 9:32 PM ET